June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Longitudinal Assessment of Retinal Ganglion Cell Degeneration In Vivo
Author Affiliations & Notes
  • Gustavo Munguba
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Daisy Lam
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Ling Ge
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Sanja Galeb
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Sinthia Samad
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Mary Tapia
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Andrew Camp
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Xiaoli Xing
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Richard Lee
    Ophthalmology, University of Miami BPEI, Miami, FL
  • Footnotes
    Commercial Relationships Gustavo Munguba, None; Daisy Lam, None; Ling Ge, None; Sanja Galeb, None; Sinthia Samad, None; Mary Tapia, None; Andrew Camp, None; Xiaoli Xing, None; Richard Lee, National Eye Institute (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2245. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Gustavo Munguba, Daisy Lam, Ling Ge, Sanja Galeb, Sinthia Samad, Mary Tapia, Andrew Camp, Xiaoli Xing, Richard Lee; Longitudinal Assessment of Retinal Ganglion Cell Degeneration In Vivo. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2245.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate the progressive nature of injury-induced neurodegenerative structural changes occurring following injury to retinal ganglion cell (RGC) axons, including spatial information by taking advantage of recent advances in in-vivo imaging techniques and assess whether structural changes to the RGC+IP layers correlate well with direct assessment of RGC density.

 
Methods
 

All animals used in this study were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the UM-IACUC. To track degenerative progress in retinas following optic nerve crush (ONC) injury, we used Bioptigen’s SD-OCT system and manual segmentation of OCT images. RGC density was measured by confocal laser scanning ophthalmoscope (CSLO) (HRA2; Heidelberg Engineering) and counts were performed using blood vessels as landmarks with which to track anatomically defined progressive RGC loss.

 
Results
 

Approximately 50% of RGCs homogeneously distributed throughout the retina of our transgenic line express Thy-1 promoter driven EYFP, labeling RGC dendrites, soma and axons. Static histology studies 3 weeks after optic nerve crush injury show a >70% reduction in the number of Brn3a and GFP positive RGCs present in injured retinas as compared to sham injury control. Unlike histology findings, in vivo density of RGCs expressing EYFP, as tracked by CSLO, progressively decreases as a consequence of ONC injury and can be tracked in a dynamic manner providing both spatial information and nature of progression. RGC+IP layer thickness decreases in response to ONC injury serve as a reliable surrogate structural marker for RGC death. Changes in RGL+IPL thickness heat-maps provide spatial information regarding progressive RGC axonal loss.

 
Conclusions
 

In vivo CSLO imaging can track EYFP expression by RGCs, providing dynamic assessment of CNS neuron survival following injury. The use of RGC+IP layer thickness as a surrogate marker for RGC survival is an effective method to follow progressive loss of RGC soma and axons after axonal injury. In vivo visualization of neuron specific gene expression to follow cell survival in a progressive manner may provide a more dynamic view of animal model disease pathophysiology than conventionally used histologic methods. Assessment of RGC density by CSLO is a potentially useful clinical application.

     
Keywords: 568 intraocular pressure • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 426 apoptosis/cell death  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×